Yle Investigates ‘Cancer Drug Scandal’ Background – Statistics Reveal Rise in One Drug

Yle investigated the ‘cancer drug scandal’ revealing that a significant increase in the sales of one cancer drug was a key factor. The Finnish government and Kela (the health insurance fund) are adding new drugs to a list that are not reimbursed by the state. The government assures that drug availability is not at risk.

Summarized from the sources above. Read the originals for the full story.